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A model for the pro-PQQ cofactor of Thiobucillus versutus methylamine dehydrogenase was fitted into a 2.25 A resolution 
electron density distribution for this enzyme. This proposed model of pro-PQQ consists of a tyrosine-derived quinone 
indole bicyclic structure. Linkage of the cofactor to the light subunit of the enzyme occurs via the side chain of glutamate 
57, which is itself bound to the side chain of arginine 107 of that subunit. Since the elements of this cofactor are derived 
from tyrosine, glutamate and arginine, we have named it ‘TGA pro-PQQ’. 
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1. INTRODUCTION 
The Gram negative bacterium Thiobacillus ver- 
sutus is a methylotroph, i.e. it is capable of growth 
using Cl compounds as sole source of carbon and 
energy. When methylamine is the growth substrate, 
the first step in the carbon dissimilation pathway is 
the oxidation of the substrate by the enzyme 
methylamine dehydrogenase (MADH) (EC 
1.4.99.3) to obtain formaldehyde and ammonia 
[ 11. The reducing equivalents are then transferred 
to a c-type cytochrome via a type I blue copper pro- 
tein, amicyanin [2]. 
MADH is a tetrameric enzyme, made up of two 
heavy (H) and tow light (L) subunits [3]. In the ear- 
ly stage of the characterization of this enzyme, it 
became obvious that it contained a very tightly 
bound organic cofactor, which resembled that of 
the copper-containing diamine oxidase enzymes 
(EC 1.4.3.6) [4]. Later, ESR and ENDOR spectra 
of the native enzyme indicated that the cofactor 
had a quinone structure, and that it was very 
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similar to the cofactor found in the enzyme 
methanol dehydrogenase (MDH) (EC 1.1.99.8) [5]. 
Since the latter was identified as pyrroloquinoline 
quinone (or PQQ) [6,7], the MADH cofactor was 
also assumed to be PQQ, or a closely related com- 
pound. The observed differences in the ENDOR 
spectra of MDH and MADH were attributed either 
to differences in the structures of the two cofac- 
tors, or to differences in the interactions between 
cofactor and enzyme [5]. 
Sequence studies carried out on the L subunit of 
the Pseudomonas AMI MADH revealed that the 
enzyme cofactor was covalently bound to two 
residues of that subunit [S], but the nature of the 
residues binding the cofactor could not be 
established. More recently, mass spectroscopy of 
the semicarbazide adduct of the cofactor of the 
MADH from Bacterium W3AZ suggested that this 
prosthetic group had a tricyclic PQQ nucleus-like 
structure, but lacking the three carboxylate groups 
of PQQ [9]. Linking of the cofactor to the L sub- 
unit of MADH was proposed to occur via one Cys 
thioether bond and one Ser oxygen ether linkage. 
However, derivatization of the intact, protein 
bound cofactor of the T. versutus enzyme with 
phenylhydrazine (PH), followed by proteolysis and 
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acid treatment gave compounds with the same 
spectroscopic and chromatographic properties as 
the adducts of authentic PQQ with PH [lo]. 
Therefore, it was concluded that the MADH cofac- 
tor was integral PQQ, linked to the L subunit via 
pronase-sensitive peptide or ester bonds. 
In order to elucidate the active site of this en- 
zyme with its unusual cofactor, as well as to study 
the exact role of this PQQ-related cofactor in the 
enzyme-catalyzed reaction and subsequent electron 
transfer, we have determined the 3D structure of 
the MADH from Thiobacilus versutus by X-ray 
crystallographic methods. A 2.25 A resolution 
electron density map for the native enzyme was 
recently obtained, in which the polypeptide chain 
could be followed in both the H and the L subunits 
[I 11. In this map, the electron density correspon- 
ding to the quinone cofactor suggested that only 
two of the three rings of PQQ were present in the 
MADH cofactor. Since PQQ biosynthesis is 
thought to involve the addition of a glutamate 
residue to a tyrosine-derived quinone indole bi- 
cyclic ring structure [12,13], we proposed the 
presence in MADH of a similar, ‘open-form’ pro- 
PQQ cofactor having a 9a-y-glutamyl indole struc- 
ture [II]. 
However, while this previous model of the pro- 
PQQ cofactor fitted nicely into the electron density 
of the cofactor region, we experienced problems 
when trying to model the postulated linkages from 
the prosthetic group both to the side chain of 
residue 57, and to that of residue 107 of the L sub- 
unit. In order to shed more light on the exact 
nature of the cofactor of MADH, we have been 
carrying out further model building studies in the 
electron density obtained for this cofactor. The 
molecular structure for the cofactor presented in 
this paper agrees with the available chemical infor- 
mation. 
2. EXPERIMENTAL 
A 2.25 A resolution density distribution for T. versutus 
MADH was calculated from structure factor amplitudes obtain- 
ed from crystals grown as described previously [14]. Phases were 
initially determined by the isomorphous replacement method, 
complemented in later stages by solvent flattening and crystallo- 
graphic refinement of the atomic model [1 11. The model used 
for phase calculation consisted of the polypeptide chains of both 
subunits of the enzyme, in which an X-ray sequence had been 
assigned to each subunit type [ll]. This model gave an R-factor 
value of 28.6% with all measured data from 6.0 to 2.25 A 
resolution. 
Graphic work was carried out on an Evans & Sutherland 
PS390 picture system, where electron density maps and 
molecular models were displayed simultaneously. This, together 
with the interactive manipulation of models and regularization 
of these models using Jan Hermans algorithm [15] was carried 
out with the macromolecular crystallography display and model 
building program FRODO 1161. The quinone indole model was 
docked manually into the native electron density corresponding 
to the cofactor region in the active site of MADH. Using the 
SAM option of the program FRODO [16], the side chains of the 
two cofactor binding residues were mutated from alanine to 
glutamine and from serine to arginine at positions 57 and 107 of 
our previously determined X-ray sequence [1 11 of the L subunit. 
These two side chains were positioned optimally into the re- 
maining (i.e. not occupied by the quinone indole moiety) elec- 
tron density at the cofactor site by rotation about single bonds, 
followed by regularization of the resulting structure. 
3. RESULTS AND DISCUSSION 
When the native 2.25 A resolution electron den- 
sity distribution of T. versutus MADH, became 
available, we were able to fit a complete model for 
the polypeptide chains of both H and L subunits in- 
to this density [ 111. During this step, assignment of 
side chains had been done solely on the basis of the 
electron density, and of the interactions which were 
observed between these side chains and other parts 
of the structure. The establishment of this ‘X-ray 
sequence’ was necessary due to the lack of any se- 
quence information available at that time. 
A partial preliminary amino acid sequence has 
recently been obtained for a short stretch of 31 
residues in the H subunit of the T. versutus enzyme 
(Huitema, F., Beintema, J. J. and Duine, J.A., per- 
sonal communication). The quality of the electron 
density map which was used to deduce the X-ray se- 
quence can be judged from the results of the com- 
parison of this X-ray sequence with the chemical 
sequence: in this short segment we observed 14 
residues which had been perfectly identified from 
the electron density map while the remaining 17 
residues differed marginally from the correct 
chemical sequence. In particular the solvent inac- 
cessible residues agreed well in the two sequences. 
Therefore, we believe that a reasonable amount of 
structural information can be deduced from our 
map. 
The electron density corresponding to the 
quinone cofactor of MADH indicates that only the 
quinone indole portion of the PQQ molecule can 
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be found in the cofactor of this enzyme. The re- 
maining density of this cofactor region is not co- 
planar with the density corresponding to the 
quinone indole group, and the 9a-y-glutamyl in- 
dole moiety which we proposed earlier as the pro- 
PQQ cofactor of MADH gives a nice fit into the 
electron density [ 111. 
However, some difficulties were encountered for 
the proposed linkages of this cofactor to the en- 
zyme: there is not enough density to accomodate 
I3 H,N' so 
HO, /Lx 
i H’NH, 
0 
e 
“\ OH 
Y 
without strain the proposed C9’ ester bond to 
residue 57, while the distance between the N6 atom 
of the cofactor and the side chain atom of residue 
107 is too long for the proposed linkage. There- 
fore, a major revision of the pro-PQQ model was 
required to better explain the electron density. 
In doing so the following information has been 
taken into account: (i) glutamate and tyrosine are 
the two precursors of PQQ biosynthesis [12,13]; 
(ii) the procedure used for the extraction of PQQ 
d 
“\ OH Y 
0 
Fig.1. Schematic drawing of the proposed model for the 
quinone cofactor of MADH, with a possible route for the for- 
mation of the PQQ-phenylhydrazone adduct from this cofac- 
tor. (a) The TGA pro-PQQ cofactor of MADH and its proposed 
relation to residues 57 and 107 of the L subunit; (b) after 
derivatization of this cofactor with phenylhydrazine; (c) after 
cleavage of peptide bonds by pronase treatment and acid hydro- 
lysis; (d) after rotation about the C9a-Cr bond, leaving the (Y- 
amino group of glutamate 57 in close proximity to the CSa 
hydroxyl group of the quinone indole structure; (e) after ring 
closure to form the PQQ-phenylhydrazone adduct. 
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from MADH occurs in conditions in which peptide 
bonds can be hydrolyzed or proteolytically cleaved 
[lo]; (iii) during chemical synthesis of PQQ, ring 
closure from an ‘open-form’ bicyclic ring inter- 
mediate takes place easily to generate the tricyclic 
PQQ nucleus structure [ 171. This resulted in an im- 
proved proposal for the structure of the pro-PQQ 
cofactor of MADH (fig.la). This cofactor contains 
the previously described quinone indole moiety 
[ 111, which is bound by a C9,-Cy linkage to the side 
chain of Glu-57. The latter is in turn linked via a 
peptide bond involving its y-carboxylate group to 
the Ne atom of Arg-107. Since the elements of this 
quinone cofactor are derived from three amino 
acids, namely tyrosine, glutamate and arginine, we 
propose that it should be named ‘TGA pro-PQQ’. 
The generation of the PQQ-phenylhydrazone 
adduct from MADH [lo] can be easily explained 
from this model (fig.1): after formation of the 
hydrazone at the C5 position of the quinone indole 
group, pronase treatment and acid hydrolysis will 
produce the 9a-y-glutamyl indole hydrazone, 
which undergoes cyclization and oxidation in the 
reaction conditions [lo] to yield the required 
product. 
The current model for the MADH cofactor, in- 
cluding the postulated linkages to the side chains of 
residue 57 and 107 of the L subunit, gives a nice fit 
into the electron density, whose features are now 
all explained by this model (fig.2). The proposed 
orientation of the quinone indole fused ring struc- 
ture has been confirmed by the calculation of a 
3.0 A resolution IF,-F,j difference Fourier map 
using amplitudes obtained from a crystal which 
had been treated with a phenylhydrazine [111, and 
phases from that partially refined structure with an 
R factor of 24.2% for data between 8.0 and 3.0 A 
resolution. This map showed, in addition to the 
electron density for the MADH cofactor, that cor- 
responding to the inhibitor, connected at the pro- 
posed C5 position of the quinone indole group. 
In view of the proposed in situ synthesis of the 
cofactor, both for those quinoproteins containing 
non-covalently bound PQQ [ 13,181, as well as for 
those containing a covalently bound cofactor [19], 
the current model for the pro-PQQ cofactor of 
MADH is an attractive hypothesis: both synthesis 
and linkage of this cofactor to MADH might pro- 
ceed on the enzyme itself. With respect to the 
‘covalent’ class of quinoproteins, it is interesting to 
consider the enzyme diamine oxidase, whose cofac- 
tor bears resemblance to that of MADH [4]. 
Recently, results were reported of the sequence 
analysis of a tryptic peptide containing the phenyl- 
hydrazone adduct of the cofactor, obtained from 
the pig kidney enzyme [20]. These results led to the 
Fig.2. Stereo view of the active site of MADH showing the proposed TGA pro-PQQ structure and the protein model in this region of 
the molecule (thick lines), together with the corresponding 2.25 A resolution electron density contoured at la above the average of the 
map (thin lines). This electron density map was calculated using combined solvent flattening and refined protein model phases. The 
atoms of the cofactor were not included for crystallographic refinement and phase calculation in order to minimize model bias. Labels 
indicate the Co positions of cofactor binding residues 57 and 107. 
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proposal of this cofactor being a PQQ molecule, 
linked to the protein via a peptide bond between 
the C2 carboxylate group of the cofactor and the 
N{ atom of a lysine residue [20]. The model pro- 
posed in the current paper for the pro-PQQ cofac- 
tor of MADH also contains such a peptide bond, 
linking the Cy (or C9 in the notation for the PQQ 
cofactor) carboxylate group of the quinone indole 
bound Glu-57 to the Ne atom of Arg-107. Since the 
reactions catalyzed by these enzymes differ only at 
the level of the transfer of electrons from the sub- 
strate to the respective electron acceptors, and 
since their respective cofactors are known to be 
similar [4], the diamine oxidase enzymes might also 
contain such an ‘open-form’ pro-PQQ cofactor. 
The discovery that the electron density for the 
MADH cofactor does not accomodate the full ring 
system of PQQ indicates that the commonly used 
procedures to classify an enzyme as a member of 
the group of quinoproteins [5,10,21] are unable to 
distinguish between the different but related cofac- 
tors which are found in these proteins. Obviously, 
new procedures are required for the detection and 
characterization of PQQ and of PQQ related co- 
factors as they occur in the active sites of quinopro- 
teins. Once such procedures are available, it will be 
most interesting to see how well our proposed TGA 
pro-PQQ cofactor will agree with the new ex- 
perimental data. 
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